Very low-carbohydrate ketogenic diet may have beneficial metabolic and weight loss effects, however, adhering to this diet may be challenging. Keyto is a self-monitoring and app-enhanced intervention to help individuals learn about and monitor their breath acetone (a measure of ketosis) levels to promote dietary change and weight loss. The purpose of this research is to test the Keyto self-monitoring + app intervention against a "standard of care" weight loss dietary app (Weight Watchers). 144 participants will be recruited through Facebook ads, provide online consent, and will be randomized to one of the two conditions. Weight loss after 12 weeks will be assessed as the primary outcome, with weight loss at 24 and 48 weeks being secondary outcomes. Blood samples will be collected at baseline and 12 weeks with optional blood samples at 48 weeks follow up.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
155
Keyto is a self-monitoring and app-enhanced intervention to help individuals learn about and monitor their breath acetone (a measure of ketosis) levels to promote a very low carbohydrate diet and weight loss.
The Weight Watchers app helps people to monitor their food intake, track points and provides recipe ideas to support weight loss.
University of British Columbia
Kelowna, British Columbia, Canada
Change in body mass at 12 weeks
Change in body mass (in kilograms)
Time frame: 12 weeks from baseline
Change in body mass at 24 and 48 weeks
Change in body mass (in kilograms)
Time frame: 24 and 48 weeks from baseline
Carbohydrate intake
Total consumption of carbohydrates in 24 hour period (in grams)
Time frame: 12, 24, and 48 weeks from baseline
Total fat intake
Total consumption of fat in 24 hour period (in grams)
Time frame: 12, 24, and 48 weeks from baseline
Saturated fat intake
Total consumption of saturated fat in 24 hour period (in grams)
Time frame: 12, 24, and 48 weeks from baseline
Polyunsaturated fat intake
Total consumption of polyunsaturated fat in 24 hour period (in grams)
Time frame: 12, 24, and 48 weeks from baseline
Monounsaturated fat intake
Total consumption of monounsaturated fat in 24 hour period (in grams)
Time frame: 12, 24, and 48 weeks from baseline
Total energy intake
Total energy intake in 24 hour period (in kilocalories)
Time frame: 12, 24, and 48 weeks from baseline
HbA1C
Blood test will be used to determine changes in HbA1C
Time frame: 12 and 48 weeks from baseline
Fasting glucose
Blood test will be used to determine changes in fasting serum glucose
Time frame: 12 and 48 weeks from baseline
Fasting insulin
Blood test will be used to determine changes in fasting serum insulin
Time frame: 12 and 48 weeks from baseline
Fasting high-sensitivity C-reactive protein
Blood test will be used to determine changes in fasting serum high-sensitivity C-reactive protein
Time frame: 12 and 48 weeks from baseline
Fasting homeostasis model assessment of insulin resistance (HOMA-IR)
Blood test will be used to determine changes in HOMA-IR
Time frame: 12 and 48 weeks from baseline
Fasting total cholesterol
Blood test will be used to determine changes in serum total cholesterol
Time frame: 12 and 48 weeks from baseline
Fasting high-density lipoprotein (HDL) cholesterol
Blood test will be used to determine changes in serum HDL cholesterol
Time frame: 12 and 48 weeks from baseline
Fasting lipoprotein fractions
Blood test will determine changes in serum lipoprotein fractions measured by ion mobility
Time frame: 12 and 48 weeks from baseline
Fasting lipoprotein (a)
Blood test will determine changes in serum lipoprotein (a)
Time frame: 12 and 48 weeks from baseline
Fasting triglycerides
Blood test will determine changes in serum trigylcerides
Time frame: 12 and 48 weeks from baseline
Fasting non-HDL cholesterol
Blood test will determine changes in serum non-HDL cholesterol
Time frame: 12 and 48 weeks from baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.